The Israeli MGuard Registry

NCT00922337 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2014-03-06

No results posted yet for this study

Summary

the objective of the Israeli MGurad Registry is to evaluate the 'Real World' Clinical Performance of the InspireMD MGuard Coronary Stent System

Conditions

  • Ischemic Heart Disease
  • Acute Coronary Syndrome
  • Acute Myocardial Infarction

Interventions

DEVICE

MGuard Coronary Stent system

MGuard Coronary Stent system implanted within a PCI

Sponsors & Collaborators

  • InspireMD

    lead INDUSTRY

Principal Investigators

  • Elad Yaacoby · InspireMD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2013-06-30
Completion
2013-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00922337 on ClinicalTrials.gov